the good results of our investigation and improvement attempts, together with our capability to innovate to contend effectively;Furthermore, the resolutions, and particularly Novartis’s position for a repeat FCPA offender, underscore the worth for all businesses to proactively and frequently Examine and revise their compliance courses in see of e